2022
DOI: 10.1007/s11010-022-04452-x
|View full text |Cite
|
Sign up to set email alerts
|

Studying molecular signaling in major angiogenic diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 125 publications
0
3
0
Order By: Relevance
“…For example, vegf is a commonly known gene for promoting neovascularity and binds to the receptor vegfr or co‐receptor nrp1 in cell membrane to initiate angiogenesis (Lyu et al, 2020). Also, the stimulus for the expression vegf gene may come from environmental hypoxia ( hif‐1 ) or other pathological condition (Nathan et al, 2022). Additionally, the expression of inos and cox‐2 has been reported in angiogenesis.…”
Section: Introductionmentioning
confidence: 99%
“…For example, vegf is a commonly known gene for promoting neovascularity and binds to the receptor vegfr or co‐receptor nrp1 in cell membrane to initiate angiogenesis (Lyu et al, 2020). Also, the stimulus for the expression vegf gene may come from environmental hypoxia ( hif‐1 ) or other pathological condition (Nathan et al, 2022). Additionally, the expression of inos and cox‐2 has been reported in angiogenesis.…”
Section: Introductionmentioning
confidence: 99%
“…ahr1a and ahr1b were also significantly downregulated in Tg( drl : hoxa9 ; hsp70 : meis1 ), consistent with the previous finding showing that diminished AHR signalling drives human AML stem cell maintenance [ 48 , 49 ]. Other downregulated genes were tmem88a , trim2a , ephB4 , jag2b , notch3 and unc5b , which are known to regulate vascular development [ 50 ]. We validated the expression of the representative genes by qPCR assay ( figure 5 e ).…”
Section: Resultsmentioning
confidence: 99%
“…The angiogenetic pathology usually commences from so-called “angiogenic switch”, a process describing the imbalanced tilt between proangiogenic and antiangiogenic regulators toward activators, leading to the recruitment of independent blood supply in malignancies and dysregulation of tissue vascularization in other diseases, respectively 270 , 273 . Many excellent reviews are on hand describing dissect angiogenic mechanisms in different diseases, which will not be discussed here in detail 271 , 274 , 275 , 276 . The tumor-educated angiogenesis in malignancies is frequently manifested as upregulation of VEGF with significantly higher expression of VEGF in many types of solid tumors, probably resulting from tumor cell infiltration, metabolic alterations, and tissue hypoxia 271 , 277 .…”
Section: Lessons To Learn From Cancer Complications and Comorbiditiesmentioning
confidence: 99%